Novartis signs world’s first licensing deal for high-priced cancer drug – Novartis AG agreed to allow generic drugmakers in 7 middle-income nations to produce a leukemia treatment as part of a public health initiative, the first time a voluntary license has been granted for a patented cancer drug.
- The oral drug called nilotinib is used to treat chronic myeloid leukemia.
- The Medicines Patent Pool aims to boost access to medicine for people.
★★★★ You Can Also Read ★★★★
|Computer Awareness Quiz Questions Set (Banking)|
|Read Daily Current Affairs Topic Wise|
|Daily Current Affairs Quiz (Current GK Test)|
|Static Gk Quiz Questions and Answers|
For all the latest Updates, download PrepareExams App.